We are investigating the fairness of the price of $28.60 per share in cash for which Everbridge, Inc. (Nasdaq: EVBG) (“Everbridge”) has agreed to be sold to Thoma Bravo. The sales price is below the price targets for Everbridge of at least two Wall Street analysts (source: TipRanks).
If you remain an Everbridge shareholder and question the fairness of the price, you may contact our firm to discuss your legal rights at no charge by completing and submitting the form below.
Why is there an investigation?
On February 5, 2024, Everbridge announced that it had agreed to be sold to Thoma Bravo for $28.60 per share in cash.
“We are investigating whether the Everbridge Board of Directors acted in the best interests of Everbridge shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the price agreed upon is fair to Everbridge shareholders, as well as whether all material information regarding the transaction has been fully disclosed.”
Notably, according to TipRanks, the sales price is below the price targets of $35.00 per share of Scott Berg at Needham, and $32.00 per share of Michael Walkley at Canaccord Genuity.